Vineet Laboratories Limited announced that its Rights Issue Committee of the Board of Directors, in a meeting held on December 17, 2025, approved key aspects of a Rights Issue. The company plans to issue 99,87,258 fully paid-up Equity Shares, each with a face value of ₹10, at a price of ₹30 per share. This includes a premium of ₹20 per share. The total issue size, assuming full subscription, amounts to ₹29,96,17,740 (₹29.96 crore). The full issue price of ₹30 per share will be payable upon application. The Rights Issue is structured with an opening date of January 1, 2026, and a closing date of January 21, 2026. Key dates for renunciation include January 16, 2026 (Last date of On-Market Renunciation) and January 20, 2026 (Last date of Off-Market Renunciation). The record date for determining eligible equity shareholders entitled to receive rights entitlements is December 23, 2025. The Rights Entitlement Ratio is set at 13 Rights Equity Shares for every 12 Equity Shares held as of the record date. Prior to the issue, the company has 92,19,008 equity shares outstanding, which are expected to increase to 1,92,06,266 equity shares post the Rights Issue, assuming full subscription. The committee also adopted the Letter of Offer, which will be filed with the BSE, NSE, and SEBI, and subsequently dispatched to eligible shareholders. The Rights Issue Committee meeting commenced at 2:00 PM and concluded at 3:00 PM.
